Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases.
Bacsur P, Resál T, Sarlós P, Iliás Á, Dalma Sümegi L, Kata D, Dávid A, Farkas B, Ivány E, Bálint A, Bősze Z, Fábián A, Bor R, Szepes Z, Afif W, Bessissow T, Farkas K, Lakatos PL, Molnár T. Bacsur P, et al. Among authors: szepes z. Therap Adv Gastroenterol. 2024 Oct 16;17:17562848241290636. doi: 10.1177/17562848241290636. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39464507 Free PMC article.
The complex relationship between viruses and inflammatory bowel disease - review and practical advices for the daily clinical decision-making during the SARS-CoV-2 pandemic.
Farkas K, Pigniczki D, Rutka M, Szántó KJ, Resál T, Bor R, Fábián A, Szepes Z, Lázár G, Molnár T. Farkas K, et al. Among authors: szepes z. Therap Adv Gastroenterol. 2021 Apr 12;14:1756284820988198. doi: 10.1177/1756284820988198. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 33953797 Free PMC article. Review.
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study.
Bacsur P, Matuz M, Resál T, Miheller P, Szamosi T, Schäfer E, Sarlós P, Iliás Á, Szántó K, Rutka M, Bálint A, Milassin Á, Fábián A, Bor R, Szepes Z, Molnár T, Farkas K. Bacsur P, et al. Among authors: szepes z. Therap Adv Gastroenterol. 2022 Dec 26;15:17562848221144349. doi: 10.1177/17562848221144349. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36600684 Free PMC article.
Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls.
Bacsur P, Rutka M, Asbóth A, Resál T, Szántó K, Jójárt B, Bálint A, Ari E, Ajibola W, Kintses B, Fehér T, Pigniczki D, Bor R, Fábián A, Maléth J, Szepes Z, Farkas K, Molnár T. Bacsur P, et al. Among authors: szepes z. Therap Adv Gastroenterol. 2023 Jun 6;16:17562848231174298. doi: 10.1177/17562848231174298. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37324319 Free PMC article.
Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination.
Resál T, Bacsur P, Horváth M, Szántó K, Rutka M, Bálint A, Fábián A, Bor R, Szepes Z, Fekete J, Farkas K, Miheller P, Molnár T. Resál T, et al. Among authors: szepes z. Therap Adv Gastroenterol. 2023 Jul 14;16:17562848231183529. doi: 10.1177/17562848231183529. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37461738 Free PMC article.
Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system.
Bacsur P, Wetwittayakhlang P, Resál T, Földi E, Vasas B, Farkas B, Rutka M, Bessissow T, Afif W, Bálint A, Fábián A, Bor R, Szepes Z, Farkas K, Lakatos PL, Molnár T. Bacsur P, et al. Among authors: szepes z. Therap Adv Gastroenterol. 2024 Mar 21;17:17562848241239606. doi: 10.1177/17562848241239606. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38524790 Free PMC article.
Comparison of risk of malignancy and predictive value of diagnostic categories defined by Papanicolaou Society of Cytopathology system and WHO reporting system for pancreaticobiliary cytopathology in solid pancreatic lesions.
Vasas B, Fábián A, Bősze Z, Hamar S, Kaizer L, Tóth T, Bacsur P, Resál T, Bálint A, Farkas K, Molnár T, Szepes Z, Bor R. Vasas B, et al. Among authors: szepes z. Therap Adv Gastroenterol. 2024 Sep 26;17:17562848241271958. doi: 10.1177/17562848241271958. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39377014 Free PMC article.
160 results